• Meeting time:2014.9.18-2014.9.22
  • Abstract Submission Deadline: 2014.7.31
  • Registration Deadline: 2014.8.31

Venue: Guangzhou Baiyun International Convention Center 
Meeting Time: September 18, 2014 - September 22, 2014
Organizers: 
The Breast Specialist Branch of Guangdong Medical Doctor Association 

Sun Yat-Sen Memorial Hospital of SYSU 

The Third Affiliated Hospital of SYSU

The First Affliated Hospital of Shenzhen University

Home >> President of the Assembly membersPresident of the Assembly members
Renbin Liu, MD, PhD.
Renbin Liu, MD, PhD.

Renbin Liu

Committee Member, The International Oncoplastic Breast Surgery Symposium.

Honorary Chair, Asia Breast Cancer Collaborative Group( ABCCG)

Director, the Breast Cancer Center, The Third Affiliated Hospital, Sun Yat-Sen University, China

Director, Department of Thyroid and Breast Surgery, The Third Affiliated Hospital, Sun Yat-Sen University, China

2009-2012 Chair, Asia Breast Cancer Collaborative Group( ABCCG)

 

Education & Postdoctoral Training

 

1998 MD,PhD, Sun Yat-Sen University, China

1999 Clinical Training, Department of Surgery, Queen Mary Hospital, University of Hong Kong.

2000-2004 Clinical Training, Massachusetts General Hospital, Harvard University. USA.

 

Academic Appointments:

2000-2004 Postdoctoral Fellow, Massachusetts General Hospital, Harvard U. U.S.A.

1999-2008 Associate Professor, The First Affiliated Hospital, Sun Yat-Sen University, China

2008- Professor of Surgery, The Third Affiliated Hospital, Sun Yat-Sen University, China


Current Major Professional Society Appointments:

Honorary Chair, Asia Breast Cancer Collaborative Group, ABCCG

Committee Member, International Oncoplastic Breast Surgery Symposium(IOPBS)

Co-Director, Guangdong Breast Disease Association, China

 Editorial Board Member, Chinease Achives of General Surgery

Member, American Society of Clinical Oncology, ASCO

 

Major Academic Achievement

Presiding over more than 10 research projects, supported by National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, 211 Science Research Foundation, etc.

Published science papers on the Journal of Cancer Research, Gene Therapy, Molecular Therapy, Breast Cancer Research and Treatment, Cancer Gene Therapy, Chinese Medical Journal, International Journal of Oncology, Oncology Report, etc.


Resent publication

1. Jiani Wang, Renbin Liu, Mohamed A. Thabi t. et al. Expressions of ERβ and its variants ERβ1 and ERβcx in breast cancer and their clinical. Chinese Journal of Breast Disease. 2009(3)4: 387-397

2. Junjie Li, Jiani Wang, Renbin Liu, et al. Expression of HER-4 inbreast cancer and their clinicopathological significance. Chinese Advance of General Surgery. 2009,3(6): 430-436

3. Jiani Wang, Junjie Li, Renbin Liu, et al. Oncolytic herpes simplex virus vectors for the treatment of human breast cancer. Chinese Journal of Breast Disease. 2009, 3(6): 642-650

4. Jiani Wang, Junjie Li, Renbin Liu, et al. The Expression of ERβ and ER β1,2 on the breast cancer tissue and it significance. Chinese Journal of Breast Disease (Electronic Version). 2009,3(4):387-397

5. Junjie Li, Jiani Wang, Renbin Liu, et al. Treatment of breast cancer and breast cancer stem cells by oncolytic herpes simplex virus. Journal of SUN Yat-sen University (Medical Science). 2011,04: 426-432

6. Junjie Li, Qi Zhang,  Renbin Liu, et al. Treatment of breast cancer and breast cancer stem cells by oncolytic herpes simplex virus. Cancer Gene Therapy. 2012, 19(10):707-714

7. Pan Hu, Weigen Zeng, Renbin Liu et al. The effect of breast cancer cell of related fibroblast cell. Cancer Research Prevention and Treatment. 2012, 06: 649-653.

8. Jiang Hua, Renbin Liu. The therapeutic effect of gemcitabine with Vinorelbine as the second-line adjuvant chemotherapy. New Medicine. 2012, 43(9): 631-634.

9.    Xi Li, Wanshou Wan, Yong Huang, Renbin Liu. Invasive ductal breast cancer associated polymyositis causing respiratory failure. Breast Cancer Research and Treatment. 2011, 126(1) : 211-214.

10.    Jiani Wang, Musheng Zeng, Samuel D. Rabkin, Renbin Liu. Oncolytic herpes simplex virus treatment of metastatic breast cancer. Internation Journal of Oncology. 2012. 40(3): 757-63.

11.    Jiani Wang, Pan Hu, Musheng Zeng, Renbin Liu. Treatment of human nasopharyngeal carcinoma by oncolytic herpes simplex virus G47delta. Chinese Journal of Cancer. 2011,30(12):831-841

12. Zenan Huang, Qunai Huang, Renbin Liu, et al. The expression of Progesterone Receptor α and βin the cases of invasive ductal breast carcinoma and its significance. Chinese Journal of Advance in General Surgery. 2013, 07(04) :260 -264.

13.Weigen Zeng, Renbin Liu. The oncolytic herpes simplex virus vector G47 effectively targets breast cancer stem cells. Oncology Report, 2013. 29(3): 1108-14.

14. Weigen Zeng, Renbin Liu. The oncolytic herpes simplex virus vector G47 effectively targets breast cancer stem cells. Oncology Report. 2013. 29(3): 1108-14.

15. Weigen Zeng,, Renbin liu. An oncolytic herpes simplex virus vector, G47Delta, synergizes with paclitaxel in the treatment of breast cancer. Oncology Report. 2013. 29(6): 2355-61.